pmid,title,authors,year,journal,abstract,url,doi
41160711,Micro-Sim: Advancing antimicrobial Stewardship education through interprofessional simulation.,"Vella M, Choo LL, Lodhi I",2025,Medical teacher,"Inappropriate antibiotic prescribing remains a persistent problem, with significant knowledge gaps among students and physicians. We evaluated 180 antibiotic prescriptions showing 68% were inconsistent with trust guidelines, highlighting the need for targeted interventions.
Participants undertook a week-long program comprising interactive presentations, charts, newsletters, and the Micro-Sim simulation. Acting as infection doctors, they managed bleeps and advised on ten structured cases including assessing a septic mannikin. Pre- and postintervention questionnaires assessed knowledge, supplemented by qualitative feedback.
Across 10 sessions (
We plan to train regional facilitators and develop a virtual version of Micro-Sim to enable international dissemination.",https://pubmed.ncbi.nlm.nih.gov/41160711/,10.1080/0142159X.2025.2579098
"41153807
39771976
25921609
40244306
40225437
39842547
39017735
40301180
35249211
40327340
39641393
39066819
31656032
38797797
38367812
40281402
38289911
37265424
39680885
39541631
31978628
40148464
38965513
39408177
27765959
30617335
32346050
38273257
31501885
40241963
28481991
30617339
40592734
19072244
26246167
37682491
38968031
39854695
31965266
37588623
40567322
40115064
40416709
37160649
37862082
39369796
40305830
20978258
40036494
40055665
35326921
38448409
35351674
40533820
31128285
40379137
26947174
40235844
39757287
39458286
39906157
40286586
33676936
38636331
39803892
39233995
32328883
29435343
37054749
40674049
39852795
34310796
38908399
39386390
25680492
36040741
40292837
35337644
35200334
31162915
40415092
40001378
30943338
38124256
39671580
36107486
40499968
38265640
39970690
31537911
31022749
33323236
40529344
40613579","Artificial Intelligence in the Management of Infectious Diseases in Older Adults: Diagnostic, Prognostic, and Therapeutic Applications.","Pinto A, Pennisi F, Odelli S, De Ponti E, Veronese N, Signorelli C, Baldo V, Gianfredi V",2025,Biomedicines,,"https://pubmed.ncbi.nlm.nih.gov/41153807
39771976
25921609
40244306
40225437
39842547
39017735
40301180
35249211
40327340
39641393
39066819
31656032
38797797
38367812
40281402
38289911
37265424
39680885
39541631
31978628
40148464
38965513
39408177
27765959
30617335
32346050
38273257
31501885
40241963
28481991
30617339
40592734
19072244
26246167
37682491
38968031
39854695
31965266
37588623
40567322
40115064
40416709
37160649
37862082
39369796
40305830
20978258
40036494
40055665
35326921
38448409
35351674
40533820
31128285
40379137
26947174
40235844
39757287
39458286
39906157
40286586
33676936
38636331
39803892
39233995
32328883
29435343
37054749
40674049
39852795
34310796
38908399
39386390
25680492
36040741
40292837
35337644
35200334
31162915
40415092
40001378
30943338
38124256
39671580
36107486
40499968
38265640
39970690
31537911
31022749
33323236
40529344
40613579/","10.3390/biomedicines13102525
10.3390/vaccines12121314
10.1007/s10522-015-9578-8
10.1007/s40520-025-03021-8
10.7759/cureus.80442
10.1007/174_2024_558
10.1016/j.cmi.2025.01.009
10.1007/s40520-024-02808-5
10.1007/s40520-025-03050-3
10.1007/s40520-022-02094-z
10.1001/jamanetworkopen.2025.8867
10.1002/cam4.70426
10.1007/s40520-024-02798-4
10.1007/s40520-019-01375-4
10.1007/s40520-024-02772-0
10.1016/j.arr.2024.102237
10.1186/s12875-025-02836-8
10.1093/gerona/glad279
10.1002/14651858.CD014885.pub2
10.1002/widm.1485
10.2196/60794
10.48550/arXiv.2507.14912
10.1016/j.gerinurse.2024.10.078
10.4103/jiag.jiag_67_24
10.1016/j.psychres.2019.112732
10.1038/s41598-025-95604-8
10.1186/s12889-024-19096-3
10.3390/healthcare12191996
10.1109/JPROC.2015.2501978
10.1038/s41591-018-0316-z
10.48550/arXiv.1711.05225
10.1038/s41598-020-62922-y
10.1186/s12874-023-02138-6
10.1093/bioinformatics/btz682
10.3389/fpubh.2025.1547450
10.1093/bib/bbx044
10.1016/j.inffus.2017.10.006
10.1038/s41591-018-0300-7
10.1136/bmjment-2025-301733
10.1086/595683
10.1126/scitranslmed.aab3719
10.1108/TECHS-12-2021-0029
10.1007/s40520-023-02552-2
10.3233/THC-240087
10.2196/56155
10.1007/s00134-019-05872-y
10.1016/j.eclinm.2023.102124
10.5005/jp-journals-10071-24986
10.21037/atm-24-150
10.2147/JIR.S502837
10.1007/s40520-023-02409-8
10.2196/47346
10.1016/j.arr.2024.102529
10.2196/67437
10.1001/jama.2010.1553
10.2196/66699
10.1186/s12911-025-02953-5
10.3390/healthcare10030443
10.1021/acsphotonics.0c00841
10.1038/s41467-024-46211-0
10.1016/j.jgar.2022.03.019
10.1186/s12967-025-06488-1
10.1016/j.cmi.2019.05.013
10.1016/j.idnow.2025.105090
10.1016/j.artmed.2016.02.001
10.1007/s13205-025-04282-w
10.1007/s10096-024-05027-y
10.3390/microorganisms12101978
10.1016/j.csbj.2025.01.006
10.1016/j.sajce.2024.12.005
10.1016/j.artmed.2025.103137
10.1016/j.jhin.2021.02.025
10.1016/j.compbiomed.2024.108469
10.2196/58509
10.46234/ccdcw2024.192
10.1007/s11517-020-02165-1
10.1136/bmjresp-2017-000234
10.3390/electronics11050673
10.1016/j.jamda.2023.03.005
10.1001/jamanetworkopen.2025.21785
10.3390/vaccines13010016
10.1111/acem.14357
10.1016/j.jamda.2024.105080
10.3389/fdgth.2024.1441334
10.1016/j.cnur.2014.10.010
10.1001/jamanetworkopen.2022.29067
10.3390/s25061735
10.1016/S2589-7500(21)00276-4
10.3390/bios12020073
10.1038/s41598-025-03332-w
10.3390/antibiotics14020134
10.1056/NEJMra1814259
10.1093/ageing/afad219
10.2196/63710
10.2196/38144
10.1136/bmjopen-2024-096669
10.7416/ai.2024.2597
10.1016/j.cmpb.2025.108653
10.1038/s41591-019-0609-x
10.1055/s-0039-1677902
10.1016/S2589-7500(19)30002-0
10.2147/IJGM.S516247
10.17305/bb.2025.12378"
"41150080
38797176
38331529
38262139
40338404
38800841
36978354
36605768
30895209
40093312
7376378
33960495
33509339
40135877
39435404
36185800
35271460",Veterinarians' Perspectives on the Antimicrobial Resistance (AMR) Dashboard: A Survey of Needs and Preferences to Inform Development.,"Pellissery AJ, Denagamage T, Pedersen M, Kariyawasam S",2025,Veterinary sciences,"Antimicrobial resistance (AMR) poses a significant global threat to human and animal health, necessitating robust surveillance and stewardship tools. While existing systems address aspects of veterinary AMR, a comprehensive, user-centric dashboard for U.S. veterinarians remains a critical unmet need. This study aimed to identify U.S. veterinarians' preferences and perceived needs for such a dashboard, to help guide its design and development. A cross-sectional survey was conducted between January and March 2024, targeting U.S. veterinarians through professional channels. The survey instrument captured demographics, experiences with existing tools, preferences for data types and visualizations, desired technical specifications, and open-ended feedback. Of the 677 respondents, a near-unanimous consensus (over 75%) emerged on the importance of functionalities like antimicrobial stewardship education, off-label use guidance, surveillance data, and empirical treatment support. Over 70% expressed comfort sharing aggregated geographic and de-identified animal data. A strong preference was observed for making the dashboard accessible by veterinary colleges (78.87%), diagnostic laboratories (72.61%), and federal agencies (USDA: 71.47%, CDC: 66.67%, FDA: 62.11%), indicating a desire for a collaborative, authoritative system. The findings provide a robust foundation for developing a U.S. veterinary AMR dashboard. Future phases should adopt an iterative, user-centered design, incorporating qualitative research with diverse stakeholders and piloting a prototype with preferred institutional partners. This approach will ensure a trusted, sustainable tool that effectively translates surveillance data into actionable insights for improved animal and public health.","https://pubmed.ncbi.nlm.nih.gov/41150080
38797176
38331529
38262139
40338404
38800841
36978354
36605768
30895209
40093312
7376378
33960495
33509339
40135877
39435404
36185800
35271460/","10.3390/vetsci12100940
10.1016/S0140-6736(24)00876-6
10.1016/S2542-5196(23)00278-4
10.2460/ajvr.23.12.0294
10.1007/s11259-025-10752-6
10.1089/vbz.2023.0167
10.3390/antibiotics12030487
10.3389/fvets.2022.1068406
10.1093/ofid/ofy346
10.12688/wellcomeopenres.21010.4
10.1136/vr.106.12.260
10.1002/vetr.477
10.2807/1560-7917.ES.2021.26.4.2001359
10.1128/aac.01657-24
10.3389/fpubh.2024.1411962
10.2460/JAVMA.21.09.0431"
"41148730
36101788
28178770
29962311
37614960
33571265
30764777
28524255
28385463
25439025
23572483
21602488
27139474
34301332
40070317
24200831
37616423
26643196
34601148
39406042
33271843
38320516
33813115
25813839
16235325
39659641
39295113
17872937
31078660
18929686",Barriers and Enablers to Optimal Antimicrobial Use in Respiratory Tract Infections.,"Reali S, Cho JG, Alffenaar JW, Aslani P",2025,"Antibiotics (Basel, Switzerland)",,"https://pubmed.ncbi.nlm.nih.gov/41148730
36101788
28178770
29962311
37614960
33571265
30764777
28524255
28385463
25439025
23572483
21602488
27139474
34301332
40070317
24200831
37616423
26643196
34601148
39406042
33271843
38320516
33813115
25813839
16235325
39659641
39295113
17872937
31078660
18929686/","10.3390/antibiotics14101039
10.1183/23120541.00113-2022
10.1002/14651858.CD003543.pub4
10.1177/0300060518782519
10.1093/jacamr/dlad100
10.1371/journal.pone.0246782
10.1186/s12875-019-0917-8
10.1111/ijcp.12959
10.1016/j.ajic.2017.03.003
10.1111/ijcp.12538
10.1093/cid/cit212
10.1177/0272989X11406985
10.1128/AAC.00209-16
10.1186/s13690-021-00624-1
10.1002/bcp.70011
10.1093/cid/cit578
10.3109/02813432.2015.1114348
10.1016/j.cmi.2021.09.025
10.1016/j.diagmicrobio.2024.116541
10.3390/antibiotics9120859
10.1056/EVIDtt2300234
10.1016/j.cmi.2021.03.030
10.1586/14787210.2015.1025057
10.1002/14651858.cd003539.pub2
10.1093/jacamr/dlae192
10.1093/fampra/cmae047
10.1093/intqhc/mzm042
10.1016/j.jbi.2019.103208
10.1016/j.jbi.2008.08.010
10.1191/1478088706qp063oa"
"41148676
35065702
26603922
32938614
25747410
17446241
31873263
26507098
31150071
34943671
30895206
16902573
27575599
29136646
32436349
35959211
35348880
35089952
35415610
38887900
36992717
26573236
36846632
30045731
33593725
34593508
29102353
23213162
29150419
23673882
32134603
31668170
31049404
36028271
33409205
32273313
3068205
17244132
34827283
31174524
26429566",Co-Producing an Intervention to Reduce Inappropriate Antibiotic Prescribing Among Dental Practitioners in India.,"Bhuvaraghan A, Walley J, King R, Aggarwal VR",2025,"Antibiotics (Basel, Switzerland)",,"https://pubmed.ncbi.nlm.nih.gov/41148676
35065702
26603922
32938614
25747410
17446241
31873263
26507098
31150071
34943671
30895206
16902573
27575599
29136646
32436349
35959211
35348880
35089952
35415610
38887900
36992717
26573236
36846632
30045731
33593725
34593508
29102353
23213162
29150419
23673882
32134603
31668170
31049404
36028271
33409205
32273313
3068205
17244132
34827283
31174524
26429566/","10.3390/antibiotics14100984
10.1016/S0140-6736(21)02724-0
10.1016/S0140-6736(15)00473-0
10.1136/bmjgh-2020-003393
10.1093/cid/civ076
10.1093/jac/dkm090
10.1038/s41415-019-1002-3
10.1111/cdoe.12199
10.1001/jamanetworkopen.2019.3909
10.3390/antibiotics10121459
10.1093/ofid/ofz067
10.1038/sj.bdj.4813879
10.1371/journal.pmed.1002115
10.1371/journal.pone.0188061
10.1111/bcp.14373
10.1093/ofid/ofac361
10.1007/s00784-022-04453-6
10.1371/journal.pone.0262731
10.1093/jacamr/dlac039
10.1111/cdoe.12989
10.1016/j.ssmph.2023.101378
10.1136/jech-2015-205952
10.1016/j.worlddev.2022.105889
10.1186/s12961-018-0344-7
10.1136/bmj.n166
10.1136/bmj.n2061
10.1016/S2214-109X(17)30383-2
10.1377/hlthaff.2011.1356
10.1136/bmj.j5147
10.1097/QAI.0b013e3182920286
10.1016/j.adaj.2019.08.020
10.3399/bjgpopen18X101617
10.1136/bmjopen-2021-060304
10.1136/bmjopen-2019-033516
10.18332/pht/189989
10.1177/109019818801500401
10.1111/j.1600-0528.2007.00348.x
10.3390/antibiotics10111345
10.1186/s12909-019-1623-x
10.1093/jac/dkv336"
"41148668
39415207
35065702
39816255
38476862
37175597
25060972
40001376
35616940
37628504
35694248
26852795
37038124
35745632
37467239
38166736
40426545
39415487
40325130
38927144
36309348
38105789
35912421
40462148
10585974
25220798
37206057
39882210
40080812
33741531
26582868
38247629
36830137
33622432
28712667
37189584
37372411
40470160
32948060
31189642
39305917",Antibiotic Use in Pediatrics: Perceptions and Practices of Romanian Physicians.,"Iuhas A, Galiș R, Rus M, Petcheși CD, Balmoș A, Marinău C, Niulaș L, Futaki Z, Matioc D, Sava C",2025,"Antibiotics (Basel, Switzerland)",,"https://pubmed.ncbi.nlm.nih.gov/41148668
39415207
35065702
39816255
38476862
37175597
25060972
40001376
35616940
37628504
35694248
26852795
37038124
35745632
37467239
38166736
40426545
39415487
40325130
38927144
36309348
38105789
35912421
40462148
10585974
25220798
37206057
39882210
40080812
33741531
26582868
38247629
36830137
33622432
28712667
37189584
37372411
40470160
32948060
31189642
39305917/","10.3390/antibiotics14100976
10.1186/s12992-024-01046-8
10.1016/S0140-6736(21)02724-0
10.3389/frabi.2024.1439688
10.1155/2024/9958678
10.3390/ijms24097892
10.1099/jmm.0.074039-0
10.1001/jamanetworkopen.2022.14153
10.3390/healthcare11162307
10.3389/fphar.2022.890398
10.3399/bjgp16X683821
10.1186/s12875-023-02047-z
10.3390/ph15060713
10.1371/journal.pone.0288480
10.1186/s12875-023-02223-1
10.3390/antibiotics14050479
10.1111/jep.14173
10.1038/s41598-025-99642-0
10.3390/antibiotics13060477
10.21873/invivo.13019
10.3389/fped.2023.1289256
10.3238/arztebl.m2022.0275
10.1186/s13049-025-01415-1
10.1542/peds.104.6.1251
10.1016/j.anpede.2015.05.009
10.1177/20499361231169429
10.3389/fped.2024.1546387
10.2196/60831
10.1016/j.acap.2021.03.008
10.1093/jpids/piu086
10.3390/antibiotics13010070
10.3390/antibiotics12020224
10.1017/ice.2021.21
10.1016/j.cmi.2017.07.010
10.3390/diagnostics13081483
10.3390/genes14061231
10.2147/JMDH.S512254
10.3390/antibiotics9090610
10.1016/S2214-109X(24)00382-6"
"41148659
20857804
23327981
10580626
35731268
6386263
23057476
28467526
24799638
28427474
33957917
28993891
31017647
11821511
21653301
20517290
18662118
10219875
22455271
28723736
19561486
19995312",Antimicrobial Prophylaxis in Elective Orthopaedic Surgical Procedures at the Tertiary Care Hospital: A Prospective Observational Study.,"Kosić M, Miljković B, Barišić V, Vezmar-Kovačević S, Jovanović M, Vučićević K, Kovačević T",2025,"Antibiotics (Basel, Switzerland)",,"https://pubmed.ncbi.nlm.nih.gov/41148659
20857804
23327981
10580626
35731268
6386263
23057476
28467526
24799638
28427474
33957917
28993891
31017647
11821511
21653301
20517290
18662118
10219875
22455271
28723736
19561486
19995312/","10.3390/antibiotics14100968
10.2146/ajhp120568
10.1086/501577
10.1017/ice.2020.497
10.1007/s00268-022-06621-x
10.1111/j.1445-2197.2012.06143.x
10.1001/jamasurg.2017.0904
10.1086/676022
10.1186/s13104-017-2475-2
10.1186/s12891-021-04290-w
10.1007/s00132-017-3486-3
10.1001/jamasurg.2019.0569
10.1056/NEJMcp011603
10.1093/cid/cir301
10.1038/nrneph.2010.71
10.1586/14787210.6.4.523
10.1086/501620
10.1097/MD.0000000000006903
10.1097/SLA.0b013e3181ad5fca
10.3109/17453670903316868"
"41145199
35929641
35065702
33789754
38008421
31157116
26603922
34222945
28893183
15207010
34641903
38362471
36872455
21465929
31881071
32408900
27429495
36604393
33318116
20021682
36651403
38661290
34104272
28458801
30178033
26704633
33588842
33142711
32669092
36830154
34879697
36290076
39159269
27567604
34416911
16168785
38457130
38582533
30115074
28178770
33072690",Involvement of community health workers in antimicrobial stewardship interventions and programmes: a scoping review.,"Castro-Sánchez E, Huguet-Torres A, Yáñez-Juan AM, Bennasar-Veny M",2025,BMJ global health,"Antimicrobial resistance (AMR) poses a global health threat, especially in low-income and middle-income countries. Community health workers (CHWs) are key actors in infection management and health promotion; however, their involvement in antimicrobial stewardship (AMS) remains unclear. This study aims to assess CHWs' roles in AMS, examine their training and support, and evaluate outcomes regarding antibiotic use and resistance.
A scoping review was conducted to explore the roles, education, training and antimicrobial-related outcomes of CHWs. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines, with the protocol registered in Open Science Framework. Databases including PubMed, EMBASE and CINAHL were searched for studies published in English and Spanish. A narrative synthesis was applied to the identified articles, with the Integrated Quality Criteria for the Review of Multiple Study Designs and Quality Assessment Tool for Studies with Diverse Designs tools employed to assess the risk of bias.
Eight studies were identified, conducted in Uganda, Tanzania, Zambia, Pakistan, Bangladesh and Kenya. CHWs were involved in various AMS activities, such as infection prevention, detection and treatment of conditions such as pneumonia and gastrointestinal infections. CHWs contributed to health education, antibiotic prescription (when authorised) and improved adherence to guidelines. Positive outcomes included reduced inappropriate antibiotic use and increased community awareness of AMR. However, the effectiveness of these interventions varied depending on the local context and resources.
CHWs play an important role in promoting responsible antibiotic use and addressing AMR, particularly in underserved settings. Strengthening their training, expanding selected roles and responsibilities and improving support mechanisms should be considered to enhance their potential contribution to AMS programmes. Further research is needed to optimise CHW interventions and evaluate their long-term impact.","https://pubmed.ncbi.nlm.nih.gov/41145199
35929641
35065702
33789754
38008421
31157116
26603922
34222945
28893183
15207010
34641903
38362471
36872455
21465929
31881071
32408900
27429495
36604393
33318116
20021682
36651403
38661290
34104272
28458801
30178033
26704633
33588842
33142711
32669092
36830154
34879697
36290076
39159269
27567604
34416911
16168785
38457130
38582533
30115074
28178770
33072690/","10.1136/bmjgh-2025-020257
10.1093/jac/dkac255
10.1016/S0140-6736(21)02724-0
10.1186/s13756-021-00931-w
10.1093/jac/dkad291
10.1057/s41599-019-0263-4
10.1016/S0140-6736(15)00473-0
10.1186/s12879-017-2713-1
10.1186/1478-4491-2-7
10.1186/s12961-021-00748-4
10.4314/ejhs.v33i1.1S
10.1071/PY22052
10.1079/9781845937454.0000
10.1371/journal.pone.0226831
10.1186/s12961-020-00561-5
10.2471/BLT.15.164020
10.1007/s10900-022-01183-4
10.1136/bmjopen-2020-040350
10.1186/1478-4491-7-87
10.1590/1413-81232023282.12222022en
10.1111/jan.16195
10.1177/1715163521999417
10.1101/2020.08.27.20181826
10.4081/idr.2017.6917
10.7326/M18-0850
10.1016/j.puhe.2015.10.012
10.1186/s12913-021-06122-y
10.3390/antibiotics9110764
10.1186/s12913-020-05512-y
10.3390/antibiotics12020243
10.4102/phcfm.v13i1.3107
10.3390/antibiotics11101418
10.1371/journal.pmed.1004416
10.1186/s40545-021-00361-4
10.1001/jamahealthforum.2024.0034
10.1136/bmjopen-2023-079776
10.1186/s12960-018-0304-x
10.1186/s12960-017-0206-z
10.1002/14651858.CD003543.pub4
10.3389/fpubh.2020.493904
10.2471/B09"
"41143081
31908502
39843968
39539168
37506486
11990958
38032877
37009876
33802546
29090094
39439009
29796266
11392867
28459929
38089462
28250915
29189034
36309746
1556661
30333781
35094640
26078017
38863168
24503904
28257511
27094145
39529732
33127790
29476032
31758595
39816662",Fostering behaviour change in farm veterinary practice: 'champion' goal-setting and implementation considerations for antimicrobial stewardship.,"Bard AM, Rees GM",2025,JAC-antimicrobial resistance,"The use of antimicrobials in human and animal health care settings is considered a major driving force behind the emergence of antimicrobial resistance, encouraging a focus on evidence-based interventions aimed at promoting behaviours aligned with antimicrobial stewardship (AMS) ideals within both sectors. The Arwain complex intervention within Wales established peer networks of 'Veterinary Prescribing Champions' (VPCs) within and between Welsh veterinary practices to facilitate AMS training, support and activity. This study evaluates AMS goal setting and implementation within continuously engaged Arwain veterinary practices (
Descriptive quantitative analysis of Practice Action Plans (2020, 2024) and self-reported data on Action Plan implementation (2024), combined with qualitative analysis of participant interviews (2023) and participatory workshop feedback (2024) on challenges to implementing change, offer insight on the focus, achievements and implementation of AMS within the Arwain complex intervention.
VPCs focused on behaviour-led (practice team/farm client) and structural (farm/practice-focused) changes. All practices reported at least one change goal initiated, with the majority (73%) reporting at least one fully implemented change. AMS implementation challenges included practical and cultural considerations of veterinary practices, the complexities of delivering AMS within inter-professional teams, the situated complexity of AMS on farm and the geographic, economic, regulatory, epidemiological and attitudinal factors implicit in the practice 'outer setting'.
The Arwain complex intervention led to successful implementation of AMS changes across participating practices, with varying complexity, abstractness and completeness. Further research into the impact on antimicrobial use is needed to evaluate and inform future policy.","https://pubmed.ncbi.nlm.nih.gov/41143081
31908502
39843968
39539168
37506486
11990958
38032877
37009876
33802546
29090094
39439009
29796266
11392867
28459929
38089462
28250915
29189034
36309746
1556661
30333781
35094640
26078017
38863168
24503904
28257511
27094145
39529732
33127790
29476032
31758595
39816662/","10.1093/jacamr/dlaf181
10.2147/IDR.S234610
10.1038/s44259-024-00031-w
10.1002/vetr.4799
10.1016/j.socscimed.2023.116109
10.2460/javma.2002.220.1144
10.1016/j.jrurstud.2021.07.020
10.1371/journal.pone.0294733
10.1186/s13620-023-00236-x
10.3390/antibiotics10030253
10.1186/s13690-017-0232-6
10.1186/s43058-024-00662-0
10.1177/2050312118773261
10.1037/0003-066X.55.1.68
10.1001/jamainternmed.2017.0946
10.1093/jacamr/dlad131
10.1186/s13620-017-0085-x
10.1037/ccp0000260
10.1186/s13012-022-01245-0
10.1037/0022-3514.62.2.292
10.3389/fpsyg.2018.01879
10.1080/17437199.2021.2023608
10.12968/vetn.2011.2.7.408
10.1017/ice.2015.136
10.1002/vetr.4070
10.3138/jvme.0713-095R2
10.1371/journal.pone.0171380
10.1016/j.prevetmed.2016.03.008
10.1093/jacamr/dlae177
10.1136/vr.m4135
10.1136/vr.104701
10.1002/gsj.1456
10.1111/bcp.14184
10.3389/frabi.2023.1233698"
"41142666
21146207
18538699
19446918
16722874
29452941
33489616
28515903
34430227
31799007
28874347
29346620
29643217
31604207
22265340
33789754
40571954
38598612
33484528
34764659
29306587
34710362
39881456
40949784
32497086
35189952
34200116
34972026
26029375
12702698
10821154
2319282
26962123
26693005
24091422
10213583
31282277
32505875
8737438
16874650
38198157
15525377
8171350
2690414",Tackling the disparities in surgical site infections and related antimicrobial resistance in low- and middle-income countries.,"Farsakoury R, Sartelli M, Zughaier SM",2025,Surgery in practice and science,"The financial burden, morbidity, and mortality of surgical site infection (SSI) is a global issue. Incidence rates of SSI are high in low- and middle-income countries (LMICs), with evidence of surge in antimicrobial resistance (AMR) in these regions. This mini review aimed to collect and analyze existing data on SSI incidence and the associated AMR in LMICs to address some concerns about causes and control strategies.
MEDLINE, Embase, the Cochrane Library, Scopus, AMED, Biosis, and CINAHL were all searched for this study until June 8, 2025. We included all studies comparing disparities in surgical site infections and related antimicrobial resistance in low- and middle-income countries.
The overall SSI incidence in LMICs is higher than in high-income countries . The intertwined relationship between SSI and the rising AMR burden further complicates the issue. The emergence of AMR is driven by inappropriate antibiotic use, poor regulatory oversight and stewardship, inadequate healthcare infrastructure, economic limitations that result in incomplete or informal treatments, weak surveillance systems, and environmental contamination from hospitals, agriculture, and wastewater. Vaccination, sanitation and hygiene, infection control, education, alternative therapies consideration of, antimicrobial stewardship, and prevention, are strategies to prevent and reduce the development of AMR.
AMR is a dire global problem that requires immediate action to combat its spread. Effective AMR surveillance from a ""One Health"" viewpoint is needed in LMICs to map and track the spread of resistance. Environmental resistome sample is required to detect the factors influencing resistance. Searching for solution to colistin resistance, a last resort antibiotic, is critical.","https://pubmed.ncbi.nlm.nih.gov/41142666
21146207
18538699
19446918
16722874
29452941
33489616
28515903
34430227
31799007
28874347
29346620
29643217
31604207
22265340
33789754
40571954
38598612
33484528
34764659
29306587
34710362
39881456
40949784
32497086
35189952
34200116
34972026
26029375
12702698
10821154
2319282
26962123
26693005
24091422
10213583
31282277
32505875
8737438
16874650
38198157
15525377
8171350
2690414/",10.1016/j.sipas.2025.100315
"41142507
37823894
30706119
36298515
37691049
38330995
38395062
38382142
38966853
24499035
28970157
34669733
37366804
31023851
30689983
31840552
29226070
24461668
24684125
36584969
38633223
28941632
30840181
38136712
25909312
27098057
36242006
33411181
36434539
26112266
34754231
30700295
26937222
37998466
36177456
23960796
24809678
28002979
27394401",Appropriateness of empiric antibiotic therapy for community-acquired pneumonia: A multicenter cross-sectional study.,"Rahme D, Chmaisse HN, Salameh P",2025,Exploratory research in clinical and social pharmacy,"Community-acquired pneumonia (CAP) remains a major public health concern, with appropriate empiric antibiotic therapy critical to improving patient outcomes and combating antimicrobial resistance (AMR). Despite the availability of national guidelines, adherence among physicians in Lebanon was previously unclear.
To evaluate the appropriateness of empiric antibiotic prescribing for hospitalized CAP patients in Lebanon and identify factors associated with non-compliance with national guidelines.
A cross-sectional study was conducted in five Lebanese hospitals across various regions. Medical records of 380 adult CAP patients were reviewed. Empiric antibiotic regimens were evaluated for compliance with national CAP guidelines based on drug selection, dosage, route, and duration. Multivariate logistic regression was used to identify predictors of inappropriate prescribing.
Only 38.9 % of patients received fully guideline-concordant empiric therapy. Inappropriate prescribing was significantly associated with physician rank (residents: aOR = 29.13, 
Non-compliance with national CAP treatment guidelines is widespread in Lebanese hospitals and driven by physician experience, geographic disparities, and misalignment in antibiotic selection. Strengthening antimicrobial stewardship programs, regional training, and clinical decision support is essential to improve adherence and reduce AMR risk.","https://pubmed.ncbi.nlm.nih.gov/41142507
37823894
30706119
36298515
37691049
38330995
38395062
38382142
38966853
24499035
28970157
34669733
37366804
31023851
30689983
31840552
29226070
24461668
24684125
36584969
38633223
28941632
30840181
38136712
25909312
27098057
36242006
33411181
36434539
26112266
34754231
30700295
26937222
37998466
36177456
23960796
24809678
28002979
27394401/",10.1016/j.rcsop.2025.100669
"41141885
28515903
39104891
31334140
40657033
24049221
36702634
39850331
29417002
37887197
39156376
39103907","Awareness of Antibiotic Resistance Among Medical Professionals in Kerala, India: A Cross-Sectional Study.","Kuttikkunnummal AS, Sivan SP, Divakaran D, Salahudeen M, Vijay P, Theruvinkattil HJ, Usman SA",2025,Cureus,"Antimicrobial resistance (AMR) has emerged as a critical global health threat, undermining the effective treatment of infectious diseases. The growing challenge of antibiotic resistance is a matter of concern, driven by frequent misuse of antimicrobial agents and limited awareness among healthcare professionals. This study aimed to assess the level of antibiotic resistance awareness across diverse medical professionals in Kerala, India, and to identify demographic and contextual influences that affect awareness and stewardship practices.
A cross-sectional survey was conducted among 345 healthcare professionals, including doctors, dentists, nurses, and pharmacists across Kerala. Participants completed a validated 23-item Antibiotic Resistance Awareness Scale, supplemented with modules on demographics, formal training, and workplace factors. Data were analyzed to evaluate predictors of awareness scores.
Participants demonstrated moderate to high overall AMR awareness (mean score 73.9 ± 10.5), with the highest scores among physicians (75.8) and the lowest among nurses (69.7, p < 0.001). Significant disparities were observed by profession, training level, and practice setting. Only 23.5% reported formal AMR training, with pharmacists showing the highest training participation (44%). Males scored higher than females (mean difference 2.3, p=0.046), and practitioners in tertiary care had superior knowledge compared to those in primary care (mean difference 3.4, p=0.008). Training participation showed a positive but nonsignificant association with awareness (p=0.074).
While overall awareness of antibiotic resistance among Kerala's healthcare professionals was good, substantial disparities exist, especially among nurses and those lacking formal AMR training. These findings underscore the urgent need for targeted educational programs, integrated stewardship curricula, and resource strengthening. Addressing these gaps is essential for successful AMR mitigation and for informing future policy and curricular reforms locally and in similar contexts globally.","https://pubmed.ncbi.nlm.nih.gov/41141885
28515903
39104891
31334140
40657033
24049221
36702634
39850331
29417002
37887197
39156376
39103907/",10.7759/cureus.95204
"41141168
30297009
35804401
26362293
33012387
28539060
32424172
35039180
33144202
37887223
39029872
32918445
33602365
38996086",Emerging Role of Emergency Physicians in Antimicrobial Stewardship.,Taniguchi H,2025,Cureus,"The emergency department (ED) is increasingly recognized as a critical site for antimicrobial stewardship, where most initial antibiotic decisions occur, and emergency physicians (EPs), previously regarded as primarily focused on empiric treatment, are now emerging as leaders. Policy milestones, including accreditation standards and national guidelines, have catalyzed this transition, yet physician roles remain heterogeneous, and evidence on long-term outcomes is limited. Drawing on English-language literature, including intervention studies, descriptive reports, and policy documents, this editorial highlights how EPs contribute through guideline development, audit and feedback, culture follow-up, formulary oversight, rapid diagnostics, and educational initiatives. Evidence consistently shows improvements in prescribing appropriateness, reduced use of broad-spectrum agents, and faster optimization without compromising safety. However, barriers such as time pressure, professional culture, role ambiguity, and limited resources remain persistent. Importantly, the leadership of EPs has proven central in overcoming these obstacles, especially when supported by institutional commitment and integrated workflows. Their engagement is not only improving immediate prescribing practices but also represents a critical frontline defense against antimicrobial resistance and multidrug-resistant organisms. Looking forward, formalizing physician leadership, embedding stewardship in emergency medicine training, and building ED-specific data systems are essential to sustain safe and effective antibiotic use.","https://pubmed.ncbi.nlm.nih.gov/41141168
30297009
35804401
26362293
33012387
28539060
32424172
35039180
33144202
37887223
39029872
32918445
33602365
38996086/",10.7759/cureus.93058
41140110,Antimicrobial resistance and multidrug resistance patterns of uropathogens isolated from pregnant women with asymptomatic bacteriuria.,"Öztürk C, Kara M, Akyol R, Bolacalı M",2025,Turkish journal of obstetrics and gynecology,"This study aimed to evaluate the prevalence of asymptomatic bacteriuria (ASB) in the second half of pregnancy, identify causative microorganisms, and assess their antimicrobial resistance and multidrug resistance (MDR) patterns in Kırşehir, Türkiye.
Between April-December 2024, 182 pregnant women without urinary tract infection symptoms were screened at Kırşehir Training and Research Hospital. Midstream urine samples were cultured, and bacterial isolates were identified and tested for antimicrobial susceptibility using the BD Phoenix™ automated system. Data were interpreted according to EUCAST 2024 criteria.
ASB prevalence was 37.36%. 
ASB prevalence during second half of pregnancy was high, and a significant proportion of pathogens demonstrated MDR. The findings highlight the necessity of culture-based diagnosis and region-specific empirical therapy. High resistance to ampicillin and trimethoprim-sulfamethoxazole suggests that empirical protocols should be updated according to local antibiograms. Strengthening antibiotic stewardship and expanding routine ASB screening are critical to reducing maternal-fetal complications.
Bu çalışma, gebeliğin ikinci yarısında asemptomatik bakteriüri (ASB) prevalansını değerlendirmek, etken mikroorganizmaları belirlemek ve bunların antimikrobiyal direnç ile çoklu ilaç direnci (MDR) paternlerini incelemek amacıyla Kırşehir, Türkiye’de gerçekleştirilmiştir.
Gereç ve Yöntemler: Nisan-Aralık 2024 tarihleri arasında, Kırşehir Eğitim ve Araştırma Hastanesi’nde üriner sistem enfeksiyonu semptomu olmayan 182 gebe kadın taranmıştır. Orta akım idrar örnekleri kültüre alınmış, bakteri izolatları tanımlanmış ve antimikrobiyal duyarlılık testleri BD Phoenix™ otomatize sistemi ile yapılmıştır. Veriler, EUCAST 2024 kriterlerine göre yorumlanmıştır.
ASB prevalansı %37,36 olarak bulunmuştur. En sık patojen 
Gebeliğin ikinci yarısında ASB prevalansı yüksek olup, patojenlerin önemli bir kısmı MDR göstermiştir. Bulgular, kültür bazlı tanının ve bölgeye özgü ampirik tedavi yaklaşımlarının önemini ortaya koymaktadır. Ampisilin ve trimethoprim-sülfametoksazole karşı yüksek direnç, ampirik tedavi protokollerinin yerel antibiyogramlara göre güncellenmesi gerektiğini göstermektedir. Antibiyotik yönetiminin güçlendirilmesi ve rutin ASB taramalarının yaygınlaştırılması, maternal-fetal komplikasyonların azaltılması açısından kritik öneme sahiptir.",https://pubmed.ncbi.nlm.nih.gov/41140110/,10.4274/tjod.galenos.2025.29938
41138520,"Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutions.","Jarrett P, Coyer FM, Long D, Roberts JA, Keogh S",2025,Australian critical care : official journal of the Confederation of Australian Critical Care Nurses,"Residual drug error (RDE) is defined as the unintentional retention of medication in intravenous delivery systems after administration. This is a growing concern in the intensive care unit (ICU), particularly in regard to antibiotics.
The aim of this study was to explore clinicians' awareness of RDE, its perceived causes, and potential strategies to reduce its occurrence.
A qualitative approach using focus groups was conducted with ICU nurses, examining their awareness of RDE, contributing factors, and ideas for prevention. Thematic analysis was used to identify key themes and subthemes from the data.
Twenty-seven participants participated in four focus groups over four mandatory training days. Clinicians' experiences with RDEs in the ICU were categorised into three main themes: (i) Awareness and perception of RDEs; (ii) Potential causes of RDE, including knowledge gaps, workload pressures, and inconsistent double-checking and documentation practices; and (iii) Proposed solutions to minimise RDEs including enhanced education, standardised protocols, and improved documentation.
ICU nurses demonstrated limited prior awareness of RDE, with participants identifying multiple contributing factors including personal practice variability, drug characteristics, workload pressures, and reconstitution technique. Proposed solutions centred on targeted education, consistent double-checking and signing procedures, and concise, accessible checklists. These findings can inform the development of practical, context-appropriate strategies to improve medication accuracy and patient safety in the ICU.",https://pubmed.ncbi.nlm.nih.gov/41138520/,10.1016/j.aucc.2025.101450
"41130744
16048717
36311485
35065702
38134946
39299261
30180122
29744044
30126581
34082726
33446266
36035318
36226225
37887198
31628999
36945072
31145043
34862299
34031643
36211649
38509874
32134502
31489183
37291375
32945697
28480231
34485504
34620152
30312654
30462700
21659004
26242647","Knowledge, attitudes and practices survey on antimicrobial resistance and stewardship among pharmacy healthcare workers in 28 African countries.","Agiri O, Osena G, Bahati F, Dill D, Kalanxhi E, Ashiru-Oredope D, Alimi YH",2025,BMJ global health,"Antimicrobial resistance (AMR) is a pressing global health problem disproportionately affecting low- and middle-income countries. Inappropriate antimicrobial prescription and use exacerbate AMR. This study assesses the knowledge, attitudes and practices (KAP) toward AMR and antimicrobial stewardship (AMS) among pharmacy healthcare workers involved in antimicrobial dispensing across 28 African countries.
An online survey was distributed to collect data on KAP from HCWs who dispense antimicrobials in African countries. Responses were scored, and a 70% cut-off mark was used to differentiate between good and poor KAP. Logistic regression analysis was used to identify factors associated with good or poor KAPs.
A total of 2567 responses (40%) were received, of which 908 were from pharmacy HCWs who dispensed antibiotics in 28 countries. Of the 908 eligible respondents, 71.3% had good knowledge of AMR and AMS, 59.9% displayed good attitudes towards the burden of AMR and appropriate prescription of antimicrobials and 41.6% displayed good practices related to AMS. Patient demands and influence from pharmaceutical companies were among the factors that influenced the dispensing of antibiotics. In multivariable logistic regression, licensed pharmacists were more likely to have good knowledge of AMR than pharmacy technicians (adjusted OR (aOR) 1.78; 95% CI 1.64 to 1.93). Male dispensers were less likely to have a positive attitude towards AMR than female dispensers (aOR 0.69, 95% CI 0.51 to 0.94). Moreover, dispensers affiliated with public health facilities demonstrated better AMR practices than those affiliated with private facilities. Overall, good AMR knowledge status was significantly associated with positive attitudes (χ²=97.1, p<0.001) and practices (χ²=6.5, p<0.05) of AMR.
This study revealed limited understanding of AMR among dispensers without formal pharmaceutical training and a positive association between good knowledge and positive attitudes and practices. The findings underscore the importance of providing workplace educational materials on AMR and AMS to build capacity in healthcare institutions and promote proper antibiotic dispensing.","https://pubmed.ncbi.nlm.nih.gov/41130744
16048717
36311485
35065702
38134946
39299261
30180122
29744044
30126581
34082726
33446266
36035318
36226225
37887198
31628999
36945072
31145043
34862299
34031643
36211649
38509874
32134502
31489183
37291375
32945697
28480231
34485504
34620152
30312654
30462700
21659004
26242647/","10.1136/bmjgh-2025-019151
10.1016/S1473-3099(05)70189-4
10.1155/2022/3639943
10.1016/S0140-6736(21)02724-0
10.1016/S2214-109X(23)00539-9
10.1016/S0140-6736(24)01867-1
10.1097/PHH.0000000000000861
10.5812/ijpbs.10242
10.1186/s13756-018-0351-z
10.1016/j.mcna.2018.05.009
10.1186/s12889-021-11163-3
10.1186/s13756-020-00880-w
10.1093/jacamr/dlac062
10.1093/jacamr/dlac107
10.3390/antibiotics12101497
10.1016/j.jgar.2019.10.007
10.1186/s40545-023-00555-y
10.1080/1120009X.2019.1622293
10.1136/bmjopen-2021-054736
10.1155/2020/5917378
10.3389/fpubh.2022.880774
10.1016/j.heliyon.2024.e27564
10.1111/biom.13249
10.7189/jogh.09.020412
10.1007/s12325-023-02547-5
10.1080/14787210.2021.1826307
10.1093/ofid/ofw225
10.4102/sajid.v36i1.262
10.1186/s12889-021-11885-4
10.1016/j.ijantimicag.2018.09.022
10.1371/journal.pone.0207465
10.1016/S1473-3099(11)70054-8
10.1080/23120053.2016.1192808"
"41127176
31191076
28989448
31179281
30197696
34222940
29403295
27994621
38939359
37134062
36582301
36798105
31022197
25436105
36101578
26901404
12861082
30025154
30360517
16142656
11777803
37066121
32841415
35453222",Antimicrobial perceptions and stewardship practices among community pharmacy dispensers in Nepal.,"Shrestha B, Shrestha S, Acharya U",2025,Antimicrobial stewardship & healthcare epidemiology : ASHE,"This study assessed the perception and practice regarding Antimicrobial Stewardship (AMS) and knowledge about antibiotics among Community Pharmacy Dispensers (CPD) in selected municipalities of Kavrepalanchowk district, Nepal.
A cross-sectional study was conducted among CPD of the community pharmacies of Banepa, Dhulikhel, and Panauti in Kavrepalanchowk district, Nepal.
A structured self-administered questionnaire was administered to 58 CPD selected through census sampling technique. The questionnaire comprised of questions assessing the knowledge of antibiotics, perception, and practice regarding AMS. A bivariate analysis was done to determine association between demographic variables and dependent variables.
Majority of respondents (60.3%) had medium level of knowledge regarding antibiotics, 46.6% of the respondents had low practice scores, and 50% of the respondents had positive perceptions of AMS. A positive correlations of knowledge with perception (
The practice of AMS in community pharmacies is low despite of medium level of knowledge on antibiotics among the community pharmacy dispensers. Establishing AMS protocols specific to community pharmacies in Nepal can lead to standardized practices and improve adherence to AMS principles.","https://pubmed.ncbi.nlm.nih.gov/41127176
31191076
28989448
31179281
30197696
34222940
29403295
27994621
38939359
37134062
36582301
36798105
31022197
25436105
36101578
26901404
12861082
30025154
30360517
16142656
11777803
37066121
32841415
35453222/","10.1017/ash.2025.10158
10.1093/jacamr/dlz066"
"41127156
35065702
37155660
40570300
36757700
27080992
28095785
33428999
31075400
35062153
29514221
30281178
28748196
17923655
29237045
37325680
34799064
38089458
25286067
36716763",The relationship of prescriber training level to restricted antibiotic prescribing appropriateness at a tertiary academic hospital: a retrospective study.,"Greidanus P, LeBlanc RJ, Kabbani D, Smith SW, Doucette KE, Lau C, Bains S, Fong K, Stewart JJ, Zeggil T, Chen JZ",2025,Antimicrobial stewardship & healthcare epidemiology : ASHE,"This study aimed to compare appropriateness of restricted antimicrobial prescriptions, as assessed by antimicrobial stewardship program (ASP) prospective audit and feedback (PAF), between those ordered by medical trainees versus staff. Secondary objectives were to determine whether certain timing factors and other independent variables impacted prescription appropriateness.
Single center, retrospective cohort study.
The University of Alberta Hospital a 700-bed tertiary care hospital in Edmonton, Canada.
Prescriptions of six health-authority restricted antibiotics subject to ASP PAF between 2018 and 2023. Cases were excluded if prescriber role or prescription dates or times were unavailable.
Data from a local ASP quality improvement database was extracted. Multiple logistic regression analysis was completed with adjusted odds ratios (aOR) reported.
A total of 3,687 restricted antibiotic prescriptions subjected to PAF were included in this study, of which 1,163 (31.5%) were assessed as not appropriately prescribed. Prescriptions written by medical trainees did not have higher odds of appropriateness compared to staff (aOR 1.09 [95% CI 0.94-1.28], 
No differences were noted in restricted antibiotic prescription appropriateness between medical trainees and staff. Weekend prescriptions were less likely to be appropriate. Improved appropriateness over time may be multifactorial, including implementation of ASP preceding the pandemic. Further studies examining timing factors associated with appropriateness are needed.","https://pubmed.ncbi.nlm.nih.gov/41127156
35065702
37155660
40570300
36757700
27080992
28095785
33428999
31075400
35062153
29514221
30281178
28748196
17923655
29237045
37325680
34799064
38089458
25286067
36716763/",10.1017/ash.2025.10185
"41127150
30210143
29641617
34971358
30817026
40232941
37508288
25521847
25521846
33399190
32008696",How to leverage medication use evaluations for antimicrobial stewardship goals: a primer for physicians.,"Prasad R, Arya R, Meng L, Holubar M, Alegria W, Zimmet AN",2025,Antimicrobial stewardship & healthcare epidemiology : ASHE,"Medication Use Evaluations (MUEs) are structured quality improvement tools used to optimize medication use within healthcare systems. MUEs can explore safety concerns, high costs, or inappropriate use associated with any medication, among other factors. This can offer a valuable opportunity for Antimicrobial Stewardship Programs (ASPs) to promote stewardship goals, which often overlap with these concerns for specific antimicrobials. MUEs can also provide an avenue to promote interdisciplinary collaboration with targeted groups relevant to the ASP's goals as well as an opportunity to give trainees ownership of system-facing stewardship projects. Stewardship pharmacists may often have experience with leading this process as part of their training, but MUEs represent a gap in training for physicians. Here we provide guidance on how stewardship physicians can engage in the MUE process, from identifying relevant topics to interpreting findings and supporting implementation efforts, allowing them to contribute effectively even without prior MUE experience.","https://pubmed.ncbi.nlm.nih.gov/41127150
30210143
29641617
34971358
30817026
40232941
37508288
25521847
25521846
33399190
32008696/","10.1017/ash.2025.10189
10.1016/j.glohj.2023.02.002
10.1177/0018578718775330
10.1007/s40267-019-00688-8
10.1371/journal.pone.0195434
10.1093/cid/ciab1061
10.1111/ctr.13512
10.1111/ctr.70147
10.3390/antibiotics12071192
10.1002/phar.1506
10.1002/phar.1515
10.1093/ajhp/zxaa393
10.1016/j.idc.2019.10.008"
"41126089
32884305
35600711
34630834
38107874
31690162
39238436
37325582
29921472
31649820
39056089
28465825
27933228
26400706
25114935
27545670
34157817
39964200",A cross-sectional evaluation of rational antibiotic prescribing in Kabul based on WHO indicators.,"Ehsan H, Ibrahimkhil MA, Ahmadi M, Wardak FR, Aminpoor H, Salam A, Tariq H, Mubarak MY",2025,BMC infectious diseases,"Inappropriate antibiotic use is a major driver of antimicrobial resistance (AMR), particularly in low- and middle-income countries. To improve rational prescribing, the World Health Organization (WHO) developed core prescribing indicators and the AWaRe antibiotic classification. Evidence from Afghanistan remains scarce, especially in outpatient settings.
This cross-sectional prescription audit was conducted from June to December 2024 in six public and private hospitals in Kabul. Prescriptions were sampled from outpatient departments of internal medicine, pediatrics, surgery, and ENT. Of 623 prescriptions screened, 306 (49.1%) contained at least one antibiotic and were analyzed using WHO prescribing indicators and the AWaRe classification. Data were processed with SPSS v25.
A total of 374 antibiotics were prescribed, with an average of 1.5 per prescription. The most common agents were ceftriaxone (19.9%), metronidazole (16.0%), ciprofloxacin (12.4%), and amoxicillin (11.4%). Generic prescribing accounted for 63.3%, while 42.7% of prescriptions included parenteral antibiotics. All antibiotics were from the National Essential Medicines List. AWaRe analysis showed Watch antibiotics (58.6%) predominated, while Access antibiotics (41.4%) were underused; no Reserve antibiotics were prescribed. No culture and sensitivity testing supported prescribing.
Antibiotic prescribing in Kabul outpatient settings substantially exceeded WHO standards, with high reliance on broad-spectrum Watch-group agents, injectables, and non-generic formulations. These findings underscore the urgent need for Antimicrobial Stewardship Programs, prescriber training, and improved diagnostic capacity to ensure rational antibiotic use and contain AMR in Afghanistan.","https://pubmed.ncbi.nlm.nih.gov/41126089
32884305
35600711
34630834
38107874
31690162
39238436
37325582
29921472
31649820
39056089
28465825
27933228
26400706
25114935
27545670
34157817
39964200/","10.1186/s12879-025-11826-1
10.1002/JPER.24–0693"
